Top Markets
Coin of the day
CYduct Diagnostics, Inc. CYduct Diagnostics, Inc.

CYduct Diagnostics, Inc.

CYDX
Rank in Stocks #36385
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that... CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
Share Price
$0.5
Last synced: 2026-10-01
Market Cap
$2.62M
Change (1 day)
0.00%
Change (1 year)
85.19%
Country
US
Trade CYduct Diagnostics, Inc. (CYDX)

Category

P/S ratio for CYduct Diagnostics, Inc. (CYDX)
P/S ratio as of 2026 TTM: 0
According to CYduct Diagnostics, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for CYduct Diagnostics, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
3.67 -
US
2.78 -
IE
4.09 -
US
3.09 -
US
- -
DE